한글목차

소 건강 세계 시장은 2024년에는 99억 8,000만 달러로 평가되었으며, 2030년에는 160억 7,000만 달러에 이를 것으로 예측됩니다. 예측 기간 중의 CAGR은 8.22%를 나타낼 것으로 예측됩니다.

소 건강은 식육, 우유, 기타 농업 용도로 사육되는 소의 전체적인 행복과 생산성을 포괄합니다. 예방 접종, 바이오 보안 프로토콜, 소군 관리 전략 등의 예방 건강 관리는 질병 위험을 줄이고 생산성을 향상시키는 데 필수적입니다. 소 건강 관리를 더욱 강화하고 있습니다. 또한, 규제 당국의 지원과 식품의 안전성과 지속 가능한 축산 관행에 관한 소비자의 의식 증가가 시장의 상승 궤도에 기여하고 있습니다.

시장 성장 촉진요인

기술 진보

주요 시장 과제

질병 발생

주요 시장 동향

추적성 및 식품 안전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계 소 건강 시장에 미치는 영향

제5장 고객의 목소리

제6장 세계 소 건강 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 치료제별(백신, 구충약, 항감염제, 의료용 사료 첨가물, 기타 치료제)
  • 진단별(면역 진단 검사, 분자진단, 진단 화상, 임상 화학, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제7장 아시아태평양의 소 건강 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양: 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제8장 유럽 소 건강 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제9장 북미 소 건강시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제10장 남미 소 건강시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제11장 중동 및 아프리카 소 건강 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카: 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제12장 시장 역학

• 성장 촉진요인
• 과제

제13장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제14장 세계 소 건강시장 : SWOT 분석

제15장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제16장 PESTEL 분석

제17장 경쟁 구도

• Qiagen LLC
• Boehringer Ingelheim
• Thermo Fisher Scientific
• Elanco Animal Health
• Idexx Laboratories
• ID Vet
• Kyoritsuseiyaku Corporation
• Merck & Co Inc.
• Norbrook laboratories

제17장 10 조에티스 주식회사

제18장 전략적 제안

제19장 기업 소개와 면책사항

영문목차

The Global Cattle Health Market was valued at USD 9.98 billion in 2024 and is projected to reach USD 16.07 billion by 2030, growing at a CAGR of 8.22% during the forecast period. Cattle health encompasses the overall well-being and productivity of cattle, which are raised for meat, milk, and other agricultural uses. Maintaining optimal cattle health is crucial for ensuring animal welfare, economic efficiency, and the safety of animal-derived products. The rising global demand for meat and dairy, driven by population growth and increasing income levels, is spurring investment in cattle health solutions. Preventive healthcare practices such as vaccinations, biosecurity protocols, and herd management strategies are essential for mitigating disease risks and enhancing productivity. Advancements in veterinary diagnostics and treatment technologies are further strengthening cattle health management. In addition, regulatory support and growing consumer awareness regarding food safety and sustainable livestock practices are contributing to the market's upward trajectory.

Key Market Drivers

Technological Advancements

The cattle health sector is witnessing rapid technological evolution, with smart farming tools playing a key role in monitoring and managing animal well-being. Wearable sensors track vital parameters like temperature, heart rate, and movement, enabling early illness detection. The integration of data analytics allows farmers to interpret large volumes of herd health data, leading to informed decision-making. Remote monitoring using drones and satellite imaging supports pasture management and herd surveillance. Precision livestock farming customizes feeding, medication, and environmental conditions to individual animal needs, enhancing efficiency and outcomes. Blockchain ensures traceability across the cattle lifecycle, boosting transparency and safety. Genetic testing is increasingly used for selecting disease-resistant cattle and improving herd quality, driving innovation in breeding programs.

Key Market Challenges

Disease Outbreaks

Rising global cattle populations have heightened the risk and impact of disease outbreaks, presenting a significant challenge to cattle health management. In 2023, over 65 countries reported widespread cases of diseases such as Foot-and-Mouth Disease, Lumpy Skin Disease, and Bovine Tuberculosis, according to the World Organisation for Animal Health (WOAH). These outbreaks result in major economic setbacks due to reduced productivity, higher veterinary costs, and animal losses from culling mandates. The Food and Agriculture Organization (FAO) reported substantial declines in milk yield and cattle weight in affected regions, with severe implications for profitability. Managing and mitigating the effects of such outbreaks remains a key concern for stakeholders in the cattle industry.

Key Market Trends

Traceability and Food Safety

There is growing consumer demand for transparency and assurance in meat and dairy production, fueling the adoption of traceability systems in cattle farming. These systems offer end-to-end visibility, allowing consumers to access information about cattle origin, farming practices, and processing history. Regulatory authorities have mandated stringent traceability and food safety compliance, compelling producers to adopt robust tracking mechanisms. In cases of contamination or disease, such systems enable swift identification and containment, minimizing wider impacts. Traceability also supports disease surveillance and control, enhancing supply chain reliability. Innovations such as blockchain are being leveraged to secure data integrity, while genetic traceability is gaining momentum for breed verification and quality assurance.

Key Market Players

• Qiagen LLC
• Boehringer Ingelheim
• Thermo Fisher Scientific
• Elanco Animal Health
• Idexx Laboratories
• ID Vet
• Kyoritsuseiyaku Corporation
• Merck & Co Inc.
• Norbrook laboratories
• Zeotis Inc

Report Scope:

In this report, the Global Cattle Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cattle Health Market, By Therapeutics:

• Vaccine
• Parasiticide
• Anti-infective
• Medical Feed Additive
• Other Therapeutics

Cattle Health Market, By Diagnostics:

• Immunodiagnostic Test
• Molecular Diagnostics
• Diagnostic Imaging
• Clinical Chemistry
• Other Diagnostics

Cattle Health Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cattle Health Market.

Available Customizations:

Global Cattle Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Cattle Health Market

5. Voice of Customer

6. Global Cattle Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapeutics (Vaccine, Parasiticide, Anti-infective, Medical Feed Additive, and Other Therapeutics)
  • 6.2.2. By Diagnostics (Immunodiagnostic Test, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other s)
  • 6.2.3. By Region
  • 6.2.4. By Company (2024)
• 6.3. Market Map

7. Asia Pacific Cattle Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapeutics
  • 7.2.2. By Diagnostics
  • 7.2.3. By Country
• 7.3. Asia Pacific: Country Analysis
  • 7.3.1. China Cattle Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapeutics
      • 7.3.1.2.2. By Diagnostics
  • 7.3.2. India Cattle Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapeutics
      • 7.3.2.2.2. By Diagnostics
  • 7.3.3. Australia Cattle Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapeutics
      • 7.3.3.2.2. By Diagnostics
  • 7.3.4. Japan Cattle Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapeutics
      • 7.3.4.2.2. By Diagnostics
  • 7.3.5. South Korea Cattle health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapeutics
      • 7.3.5.2.2. By Diagnostics

8. Europe Cattle Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapeutics
  • 8.2.2. By Diagnostics
  • 8.2.3. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Cattle health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapeutics
      • 8.3.1.2.2. By Diagnostics
  • 8.3.2. Germany Cattle Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapeutics
      • 8.3.2.2.2. By Diagnostics
  • 8.3.3. Spain Cattle Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapeutics
      • 8.3.3.2.2. By Diagnostics
  • 8.3.4. Italy Cattle Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapeutics
      • 8.3.4.2.2. By Diagnostics
  • 8.3.5. United Kingdom Cattle Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapeutics
      • 8.3.5.2.2. By Diagnostics

9. North America Cattle Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapeutics
  • 9.2.2. By Diagnostics
  • 9.2.3. By Country
• 9.3. North America: Country Analysis
  • 9.3.1. United States Cattle Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapeutics
      • 9.3.1.2.2. By Diagnostics
  • 9.3.2. Mexico Cattle Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapeutics
      • 9.3.2.2.2. By Diagnostics
  • 9.3.3. Canada Cattle Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapeutics
      • 9.3.3.2.2. By Diagnostics

10. South America Cattle health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapeutics
  • 10.2.2. By Diagnostics
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cattle Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapeutics
      • 10.3.1.2.2. By Diagnostics
  • 10.3.2. Argentina Cattle Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapeutics
      • 10.3.2.2.2. By Diagnostics
  • 10.3.3. Colombia Cattle Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapeutics
      • 10.3.3.2.2. By Diagnostics

11. Middle East and Africa Cattle Health Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Therapeutics
  • 11.2.2. By Diagnostics
  • 11.2.3. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Cattle health Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Therapeutics
      • 11.3.1.2.2. By Diagnostics
  • 11.3.2. Saudi Arabia Cattle Health Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Therapeutics
      • 11.3.2.2.2. By Diagnostics
  • 11.3.3. UAE Cattle Health Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Therapeutics
      • 11.3.3.2.2. By Diagnostics

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Product Launches
• 13.3. Mergers & Acquisitions

14. Global Cattle Health Market: SWOT Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

• 17.1. Qiagen LLC
  • 17.1.1. Business Overview
  • 17.1.2. Company Snapshot
  • 17.1.3. Products & Services
  • 17.1.4. Financials (As Reported)
  • 17.1.5. Recent Developments
  • 17.1.6. Key Personnel Details
  • 17.1.7. SWOT Analysis
• 17.2. Boehringer Ingelheim
• 17.3. Thermo Fisher Scientific
• 17.4. Elanco Animal Health
• 17.5. Idexx Laboratories
• 17.6. ID Vet
• 17.7. Kyoritsuseiyaku Corporation
• 17.8. Merck & Co Inc.
• 17.9. Norbrook laboratories

17.10 Zoetis Inc. Inc.

18. Strategic Recommendations

19. About Us & Disclaimer